Picture of Consun Pharmaceutical logo

1681 — Consun Pharmaceutical News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareBalancedMid CapSuper Stock

HK-listed drugmaker Consun hits near 3-year low on weak outlook

** Hong Kong shares of Consun Pharmaceutical Group Ltd  1681.HK 
fall as much as 12.4% to HK$3.95, their lowest since February
2017, and are on track for 4th straight session of losses
    ** Stock ranks the 2nd biggest percentage decliner in the
afternoon trade, and is heading for the worse day on record with
steepest percentage decline since listing in December 2013
    ** Kidney medicines maker expects to see its 2019 profit to
drop 70-80% from a year ago due to decrease in sales revenue of
its Yulin pharmaceutical segment amid intensified competition in
the over-the-counter drug market in China  urn:newsml:reuters.com:*:nFWN29D0VI
    ** Guangdong-based pharmaceutical products maker has
underperformed the Hang Seng Commerce & Industry Index sector
 .HSNC  by 8.5 percentage points in the past one month
    ** The Hong Kong Hang Seng Commerce & Industry Index  .HSNC 
rises 1.4% on Thursday
    ** The Hang Seng China enterprises index  .HSCE  climbs
1.4%, and the benchmark index  .HSI  gains 1.3%

 ((Reuters Messaging:
donny.kwok.thomsonreuters.com@reuters.net))

Recent news on Consun Pharmaceutical

See all news